Showing results (101-110 of 516) with videos related to
Sort By:
Pageof 52
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 23, 2022
Antimicrobial activity of high-dose cefepime-tazobactam (WCK 4282) against a large collection of gram-negative organisms collected worldwide in 2018 and 2019Helio S Sader, Cecilia G Carvalhaes, Rodrigo E Mendes, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 20, 2021
Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infectionsHelio S Sader, Mariana Castanheira, Leonard R Duncan, et al.Antimicrobial Agents and Chemotherapy|June 28, 2017
Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant EnterobacteriaceaeMariana Castanheira, Michael D Huband, Rodrigo E Mendes, et al.BMC Infectious Diseases|November 5, 2024
Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacteralesHelio S Sader, John H Kimbrough, Rodrigo E Mendes, et al.Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|March 2, 2026
Tracheal melanoma in a catRicardo E Mendes, Brian O Kirby, Katherine Kirby, et al.British Journal of Cancer|November 1, 1995
Molecular and immunohistochemical analysis of P53 in phaeochromocytomaP L Dahia, R C Aguiar, A M Tsanaclis, et al.The Journal of Antimicrobial Chemotherapy|February 13, 2019
Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centresHelio S Sader, Rodrigo E Mendes, Michael A Pfaller, et al.Jac-Antimicrobial Resistance|September 8, 2022
Five-year analysis of the in vitro activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programmeCecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, et al.Diagnostic Microbiology and Infectious Disease|November 15, 2011
Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA Hospitals (2007-2009)Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.Diagnostic Microbiology and Infectious Disease|August 20, 2011
Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010)Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.Pageof 52